Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion

Molecular Medicine Reports

Volumn 14, Issue 2, 2016, Pages 1263-1268

  Yu, Jian Bo ^a   Jiang, Hao ^a   Zhan, Ren Ya ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adenosine triphosphate binding cassette transporters; Anti cancer drug; Cancer stem cells; Notch1; Tumor recurrence

Indexed keywords

CISPLATIN; FLUOROURACIL; HOE 33342; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; OXALIPLATIN; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX;

ADULT; ARTICLE; CANCER PATIENT; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURGERY; CELL ISOLATION; CELL SURVIVAL; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; STEM CELL SELF-RENEWAL; TUMOR INVASION; TUMOR RECURRENCE; UPREGULATION; WESTERN BLOTTING; ADOLESCENT; CELL SELF-RENEWAL; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CELL SELF RENEWAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; RECEPTOR, NOTCH1; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84978388133     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5391     Document Type: Article

References (25)

1. Holland EC: Gliomagenesis: Genetic alterations and mouse models. Nat Rev Genet 2: 120-129, 2001.
2. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002.
3. Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T and Toda M: Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett 28: 150-157, 2010.
4. Hirschmann-Jax C, Foster AE, Wulf GG, Fujii H, Kawakami Y, Kawase T and Toda M: A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233, 2004.
5. Challen GA and Little MH: A side order of stem cells: The SP phenotype. Stem Cells 24: 3-12, 2006.
6. Ramachandran C and Melnick SJ: Multidrug resistance in human tumors-molecular diagnosis and clinical significance. Mol Diagn 4: 81-94, 1999.
7. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
8. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
9. Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786, 2004.
10. Harris MA, Yang H, Low BE, Mukherjee J, Guha A, Bronson RT, Shultz LD, Israel MA and Yun K: Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res 68: 10051-10059, 2008.
11. Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T and Bates SE: Inhibition of P-glycoprotein (ABCB1) and multidrug resistance associated protein-1 (ABCC1)-mediate transport by the orally administered inhibitor CBT-1 (R). Biochemical Pharmacol 75: 1302-1312, 2008.
12. Phillips TM, McBride WH and Pajonk F: The response of CD24 (-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785, 2006.
13. Yu S, Zhang R, Liu F, Wang H, Wu J and Wang Y: Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem like side population cells. Oncol Rep 28: 561-566, 2012.
14. Chearwae W and Bright JJ: PPAR agonists inhibit growth and expansion of CD133+ brain tumour stem cells. Br J Cancer 99: 2044-2053, 2008.
15. Guo D, Xu BL, Zhang XH and Dong MM: Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis. Oncol Rep 28: 241-247, 2012.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
17. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219, 2005.
18. Ozvegy-Laczka C, Hegedus T, Várady G, Ujhelly O, Schuetz JD, Váradi A, Kéri G, Orfi L, Német K and Sarkadi B: High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol Pharmacol 65: 1485-1495, 2004.
19. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF and Mori M: Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24: 506-513, 2006.
20. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: Cell fate control and signal integration in development. Science 284: 770-776, 1999.
21. Lino MM, Merlo A and Boulay JL: Notch signaling in glioblastoma: A developmental drug target? BMC Med 8: 72, 2010.
22. Zhang XP, Zheng G, Zou L, Liu HL, Hou LH, Zhou P, Yin DD, Zheng QJ, Liang L, Zhang SZ, et al: Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem 307: 101-108, 2008.
23. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, et al: NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28: 5-16, 2010.
24. Sikandar SS, Pate KT, Anderson S, Dizon D, Edwards RA, Waterman ML and Lipkin SM: NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res 70: 1469-1478, 2010.
25. Zhen Y, Zhao S, Li Q, Li Y and Kawamoto K: Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett 292: 64-72, 2010.